Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of anti-viral monoclonal antibody for COVID-19 infection

Trial Profile

A clinical trial of anti-viral monoclonal antibody for COVID-19 infection

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 03 Apr 2020

At a glance

  • Drugs Anti-viral-monoclonal-antibody-therapeutics-Celltrion (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 03 Apr 2020 According to a Celltrion media release, the this trial is expected to begin by July 2020.
    • 26 Mar 2020 New trial record
    • 23 Mar 2020 According to a Celltrion media release, this trial is expected to begin in 3Q 2020.

Trial Overview

Purpose

This clinical trial will evaluate anti-viral monoclonal antibody for COVID-19 infection.

Diseases Treated

Indication Qualifiers Patient Segments
COVID 2019 infections treatment -

Subjects

  • Subject Type volunteers
  • Sex male & female

Trial Details

Organisations

  • Affiliations Celltrion

Trial Dates

  • Initiation Dates

    Planned : 01 Jul 2020

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location Unknown
  • Focus Adverse reactions; First in man

Interventions

Drugs Route Formulation
Anti-viral-monoclonal-antibody-therapeutics-CelltrionPrimary Drug
-
-

anti-viral monoclonal antibody

Trial History

Event Date Event Type Comment
03 Apr 2020 Other trial event According to a Celltrion media release, the this trial is expected to begin by July 2020. Updated 08 Apr 2020
26 Mar 2020 New trial record New trial record Updated 26 Mar 2020
23 Mar 2020 Other trial event According to a Celltrion media release, this trial is expected to begin in 3Q 2020. Updated 26 Mar 2020

References

  1. Celltrion. Celltrion Accelerates Development of COVID-19 Antiviral Treatment and Aims to Launch Rapid Self-testing Kit. Media-Rel 2020;.

    Media Release
  2. Celltrion. Celltrions COVID-19 Antiviral Treatment Enters the Next Phase of Development. Media-Rel 2020;.

    Media Release
  3. Celltrion. Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time. Media-Rel 2020;.

    Media Release
Back to top